Header image

Session 2A: Unlocking the next frontier: Building globally competitive women's health innovation

Tracks
Track 1
Wednesday, October 21, 2026
2:15 PM - 3:00 PM
Plenary / Clinical Innovation & Patient Impact Breakout Room

Details

Women's health represents one of the greatest untapped opportunities in biotechnology and medtech. Advances in technology are transforming how diseases affecting women are understood, diagnosed and treated. Yet despite the scale of the opportunity, many innovations still struggle to progress from promising science to globally successful products and companies. This panel explores what it takes to build commercially successful women's health innovations. From generating the right evidence and attracting investment to navigating regulatory pathways, scaling companies and accessing global markets, the discussion will examine how Australia can translate world-class innovation into global impact. Delegates will gain practical insights into the opportunities shaping the future of women's health and the partnerships required to accelerate innovation from discovery to patient care.


Speaker

Agenda Item Image
Dr. Kate Arnold
Program Manager
ARPA-H

Panellist

Agenda Item Image
Mrs Kate Taylor
Director Industry Engagement
Queensland University Of Technology

Chair

Agenda Item Image
Prof. Victoria Cogger
Executive Director, Sydney Biomedical Accelerator
Sydney Biomedical Accelerator

Panellist

Agenda Item Image
A/Prof. Michelle Hill
Founder & CEO
Proseek Bio

Panellist

Agenda Item Image
Dr. Raisa Monteiro
Co-founder & Ceo
Lorai Health

Panellist

Agenda Item Image
Mrs Chelsea Newell
Partner
Scale Investors

Panellist

loading